Sort
15,842 grants matching “pancreatic cancer”
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
$344,669James P Quigley · Scripps Research Institute, The · R01 · FY2009 · CA
Palmitoylation of Hedgehog Proteins
$344,564Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2011 · GM
Integration of stromal targeting agents with immune checkpoint therapy
$344,496Lei Zheng · Johns Hopkins University · P01 · FY2025 · CA
Integration of stromal targeting agents with immune checkpoint therapy
$344,496Lei Zheng · Johns Hopkins University · P01 · FY2021 · CA
Analysis of the p53 in vivo using a unique mouse model
$344,459Gerard Ian Evan · University Of California, San Francisco · R01 · FY2009 · CA
Mutant p53 as actionable cancer-specific target
$344,434Ute M Moll · State University New York Stony Brook · R01 · FY2021 · CA
Project 2: Clinical Development of the Pancreatic Cancer Drug Conjugate SW v-49
$344,339William G Hawkins · Washington University · P50 · FY2018 · CA
Polymeric nanoparticles with imaging capability for therapeutic peptide delivery
$344,267J Manuel Perez · University Of Central Florida · R01 · FY2014 · EB
Structural Basis for Chemokine Function
$344,250Brian F Volkman · Medical College Of Wisconsin · R01 · FY2017 · AI
Structural Basis for Chemokine Function
$344,250Brian F Volkman · Medical College Of Wisconsin · R01 · FY2015 · AI
Structural Basis for Chemokine Function
$344,250Brian F Volkman · Medical College Of Wisconsin · R01 · FY2018 · AI
Structural Basis for Chemokine Function
$344,250Brian F Volkman · Medical College Of Wisconsin · R01 · FY2019 · AI
Structural Basis for Chemokine Function
$344,250Brian F Volkman · Medical College Of Wisconsin · R01 · FY2016 · AI
Minimizing Uncertainty in Breast Ultrasound Imaging with Real-Time Coherence-Based Beamforming
$344,166Muyinatu A. Lediju Bell · Johns Hopkins University · R01 · FY2023 · EB
Targeting NADPH Oxidase for Pancreatic Cancer Prevention and Therapy
$344,109Weiqin Lu · University Of Texas El Paso · R01 · FY2022 · CA
UPR Activators for Cancer Therapy
$344,109Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2023 · CA
Mechanism of Pancreatic Carcinogenesis
$344,108Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2016 · CA
Mechanism of Pancreatic Carcinogenesis
$344,108Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2017 · CA
Mechanism of Pancreatic Carcinogenesis
$344,108Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2015 · CA
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
$344,094Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2018 · CA
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
$344,094Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2017 · CA
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
$344,094Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2020 · CA
Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus
$344,023Xiaoliu Zhang · University Of Houston · R01 · FY2018 · CA
Novel Strategies to Potentiate a Ras-targeted Oncolytic Herpes Simplex Virus
$344,023Xiaoliu Zhang · University Of Houston · R01 · FY2017 · CA
Gemcitabine-Radiation for Advanced Pancreatic Cancer
$343,925Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2009 · CA